Gene · 1048
Papers3,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic evaluation of a multi-target magnetic bead-enriched circulating tumor cell-enriched identification system for colorectal cancer. | J Gastrointest Oncol | 2024 | 38482239 | PubTator, text mining | PubMed |
| Establishing a carcinoembryonic antigen-associated competitive endogenous RNA network and forecasting an important regulatory axis in colon adenocarcinoma patients. | J Gastrointest Oncol | 2024 | 38482222 | PubTator, text mining | PubMed |
| A Panorama of Extracellular Vesicle Applications: From Biomarker Detection to Therapeutics. | ACS Nano | 2024 | 38471757 | PubTator, text mining | PubMed |
| SERPINB5 promotes colorectal cancer invasion and migration by promoting EMT and angiogenesis via the TNF-α/NF-κB pathway. | Int Immunopharmacol | 2024 | 38460302 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals a regulatory pattern of anoikis in human cancers. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38430038 | PubTator, text mining | PubMed |
| Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma. | Cancers (Basel) | 2024 | 38398089 | PubTator, text mining | PubMed |
| Development and characterization of DIA 12.3, a fully human intact anti-CEACAM1 monoclonal antibody. | PLoS One | 2024 | 38346003 | PubTator, text mining | PubMed |
Antibodies against Small Ubiquitin-like Modifier Activating Enzyme May Be a Protective Factor from Rapid Progressive Interstitial Lung Disease in Patients Bearing Antibodies against Melanoma Differentiation Associated Gene 5. | J Clin Med | 2024 | 38337419 | PubTator, text mining | PubMed |
| A novel exosome based therapeutic intervention against neuroendocrine prostate cancer. | Sci Rep | 2024 | 38307935 | PubTator, text mining | PubMed |
| Research Progress of SN38 Drug Delivery System in Cancer Treatment. | Int J Nanomedicine | 2024 | 38293612 | PubTator, text mining | PubMed |
| Fluorescence visualization for cancer DETECTION: EXPERIENCE and perspectives. | Heliyon | 2024 | 38293525 | PubTator, text mining | PubMed |
| New trends in diagnosis and management of gallbladder carcinoma. | World J Gastrointest Oncol | 2024 | 38292841 | PubTator, text mining | PubMed |
| A case of peritoneal Burkitt's lymphoma mimic of peritoneal tuberculosis. | Respir Med Case Rep | 2024 | 38292731 | PubTator, text mining | PubMed |
| Pulmonary Adenoid Cystic Carcinoma Mimicking Asthma-Like Symptoms: A Case Report and Literature Review. | Case Rep Oncol | 2024 | 38288460 | PubTator, text mining | PubMed |
| Two Cases of Vulval Extramammary Paget's Disease Treated with Topical Imiquimod Cream. | Indian Dermatol Online J | 2024 | 38283018 | PubTator, text mining | PubMed |
| New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. | Cancer Immunol Immunother | 2024 | 38279989 | PubTator, text mining | PubMed |
| High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive. | Biomedicines | 2024 | 38275400 | PubTator, text mining | PubMed |
| A Multimode Microfiber Specklegram Biosensor for Measurement of CEACAM5 through AI Diagnosis. | Biosensors (Basel) | 2024 | 38275310 | PubTator, text mining | PubMed |
| Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling. | Sci Rep | 2024 | 38267509 | PubTator, text mining | PubMed |
| Development of robust antiviral assays using relevant apical-out human airway organoids. | bioRxiv | 2024 | 38260306 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1048/papers?page=12